MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12974-018-1352-9

Медицинская библиотека · Journal of neuroinflammation · 2018

In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET.

Hagens Marloes H J, Golla Sandeep V, Wijburg Martijn T, Yaqub Maqsood, Heijtel Dennis, Steenwijk Martijn D, Schober Patrick, Brevé John J P, Schuit Robert C, Reekie Tristan A, Kassiou Michael, van Dam Anne-Marie, Windhorst Albert D, Killestein Joep, Barkhof Frederik, van Berckel Bart N M, Lammertsma Adriaan A

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Over the past decades, positron emission tomography (PET) imaging has become an increasingly useful research modality in the field of multiple sclerosis (MS) research, as PET can visualise molecular processes, such as neuroinflammation, in vivo. The second generation PET radioligand [18F]DPA714 binds with high affinity to the 18-kDa translocator-protein (TSPO), which is mainly expressed on activated microglia. The aim of this proof of concept study was to evaluate this in vivo marker of neuroinflammation in primary and secondary progressive MS.

METHODS

All subjects were genotyped for the rs6971 polymorphism within the TSPO gene, and low-affinity binders were excluded from participation in this study. Eight patients with progressive MS and seven age and genetic binding status matched healthy controls underwent a 60 min dynamic PET scan using [18F]DPA714, including both continuous on-line and manual arterial blood sampling to obtain metabolite-corrected arterial plasma input functions.

RESULTS

The optimal model for quantification of [18F]DPA714 kinetics was a reversible two-tissue compartment model with additional blood volume parameter. For genetic high-affinity binders, a clear increase in binding potential was observed in patients with MS compared with age-matched controls. For both high and medium affinity binders, a further increase in binding potential was observed in T2 white matter lesions compared with non-lesional white matter. Volume of distribution, however, did not differentiate patients from healthy controls, as the large non-displaceable compartment of [18F]DPA714 masks its relatively small specific signal.

CONCLUSION

The TSPO radioligand [18F]DPA714 can reliably identify increased focal and diffuse neuroinflammation in progressive MS when using plasma input-derived binding potential, but observed differences were predominantly visible in high-affinity binders.

Для цитирования: Hagens Marloes H J, Golla Sandeep V, Wijburg Martijn T, Yaqub Maqsood, Heijtel Dennis, Steenwijk Martijn D, Schober Patrick, Brevé John J P, Schuit Robert C, Reekie Tristan A, Kassiou Michael, van Dam Anne-Marie, Windhorst Albert D, Killestein Joep, Barkhof Frederik, van Berckel Bart N M, Lammertsma Adriaan A. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET.. Journal of neuroinflammation. 2018. DOI: 10.1186/s12974-018-1352-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.